We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scientific Director to present at FIDHC

11 Oct 2022 07:00

RNS Number : 3983C
Omega Diagnostics Group PLC
11 October 2022
 

REACH

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Scientific Director to present at FIDHC

Middle East event brings together industry experts and key speakers who are specialists in Gut health

 

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that Dr. Nigel Abraham, Scientific Director at Omega Diagnostics, will be presenting at the International Symposium on Food Intolerance and Digestive Health (FIDHC) in Dubai, taking place on Monday 17 October 2022.

 

Dr. Nigel Abraham, PhD, FIBMS, FRSM, is a specialist in the development, implementation, automation and validation of innovative diagnostic assays and their applications, specialising in the fields of Immunology and allergy. The presentation is entitled: "The Role of Food Sensitivity in Chronic Inflammatory Conditions".

 

FIDHC, organised by Omega's partners in the Middle East, Babirus, is an annual symposium which brings together key speakers who are experts in Gut health. The event offers a platform to educate healthcare professionals in the region about the scientific basis and clinical utility for the use of food IgG antibody testing (food sensitivity) in clinical practice.

 

The symposium attracts more than 500 medical professionals across a number of specialties, including gastroenterologists, dermatologists, pediatricians, GP's, Nutritionists, Dieticians, as well as Pathology. Delegates attending come from government health ministries, public and private hospitals, as well as primary care clinics and include many health professionals who trust Omega's food sensitivity tests and use them in their clinical practice.

 

Jag Grewal, CEO of Omega Diagnostics said: "We are thrilled to be in attendance and presenting at this prestigious symposium, attracting more than 500 medical professionals. We believe that personalised nutrition should sit at the heart of global healthcare and this event allows Omega and our Scientific Director, Dr Nigel Abraham, a platform to educate healthcare professionals in the region about the scientific basis and clinical utility for the use of food IgG antibody testing (food sensitivity) in clinical practice."

 

 

Contacts: 

 

Omega Diagnostics Group PLC

www.omegadx.com

Jag Grewal, Chief Executive Officer

via Walbrook PR

Chris Lea, Chief Financial Officer

finnCap Ltd

Tel: 020 7220 0500

Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)

Alice Lane/Charlotte Sutcliffe (ECM)

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus / Sam Allen / Lianne Applegarth

Mob: 07980 541 893 / 07502 558 258 / 07584 391 303

 

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

www.omegadx.com

 

 

 

About Dr. Nigel Abraham, PhD, FIBMS, FRSM

Nigel is Scientific Director at Omega Diagnostics Ltd., UK, and a specialist in the development, implementation, automation and validation of innovative diagnostic assays and their applications.

 

Specialising in the fields of Immunology and allergy, Nigel was trained originally in pathology at St. Georges Medical School and went on to study Immunology at the University of Surrey. A specialist in allergy and hormones he has been involved in extensive research in the field of chemical mediators of allergic disease and salivary hormone diagnostics. He is a Fellow of the Institute of Biomedical Science and a chartered scientist, formerly the Scientific Director of Genova Diagnostics (Europe), and leading a specialist laboratory team performing a comprehensive range of tests in functional and nutritional medicine. He is also a keen participant in both student and practitioner education lecturing at many of the major education centre's as well as regularly holding seminars and presentations as part of the continuing professional development for practitioners. Nigel has been involved in many research projects and have published a number of scientific papers.

 

About FIDHC

https://www.fidhc.com/

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKEEFDSAFFA
Date   Source Headline
6th Sep 20237:00 amRNSAGM Statement
1st Sep 202310:29 amRNSUpdate on proposed Share Reorganisation
31st Aug 20237:00 amRNSProposed Share Reorganisation Timetable
22nd Aug 20237:00 amRNSDirectorate Change
17th Aug 20237:00 amRNSBoard Appointment
15th Aug 20231:45 pmRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSPosting of Annual Report and confirmation of AGM
3rd Aug 20237:00 amRNSFinal Results
27th Jul 20237:00 amRNSNotice of Results
26th Jul 20232:10 pmRNSHolding(s) in Company
6th Jun 202311:19 amRNSHolding(s) in Company
5th Jun 20234:51 pmRNSHolding(s) in Company
2nd Jun 20232:45 pmRNSHolding(s) in Company
22nd May 20235:33 pmRNSHolding(s) in Company
10th May 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th May 20233:42 pmRNSDirector/PDMR Shareholding
21st Apr 20239:48 amRNSHolding(s) in Company
19th Apr 20239:31 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update
22nd Mar 20235:57 pmRNSBlock Listing Six Monthly Return
22nd Mar 20233:00 pmRNSHolding(s) in Company
6th Mar 20232:31 pmRNSHolding(s) in Company
27th Jan 20233:03 pmRNSHolding(s) in Company
27th Jan 20239:36 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSTrading update
16th Jan 202310:56 amRNSHolding(s) in Company
6th Jan 20237:00 amRNSUS expansion update
3rd Jan 202312:34 pmRNSHolding(s) in Company
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 202212:01 pmRNSHolding(s) in Company
30th Nov 20229:35 amRNSHolding(s) in Company
25th Nov 20227:00 amRNSReceipt of deferred consideration
24th Nov 20227:00 amRNSHalf-year Report
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
18th Nov 202212:09 pmRNSHolding(s) in Company
16th Nov 20222:06 pmRNSSecond Price Monitoring Extn
16th Nov 20222:00 pmRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSConfirmation of Results and Investor Presentation
14th Nov 20227:00 amRNSPartnership agreement with Software Provider
8th Nov 20229:04 amRNSLaunch of new all-employee share incentive plan
26th Oct 20222:50 pmRNSResult of AGM
26th Oct 20227:00 amRNSAGM Statement and Notice of Results
11th Oct 20227:00 amRNSScientific Director to present at FIDHC
5th Oct 20227:00 amRNSPositive WHO data received for VISITECT® CD4 test
27th Sep 20227:00 amRNSPosting of Annual Report and confirmation of AGM
20th Sep 202212:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.